ESSA Pharma Inc.
Hedge Funds Holdings
Last updated:
ESSA Pharma Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 1.57% of the total amount of its stocks outstanding. This makes up a total of 690.99K shares of ESSA Pharma Inc.. Compared to the previous quarter, the number fell by -97.93% or -32.64M shares fewer. As for the holding position changes, 28.57% (4) of current hedge fund investors increased the number of shares held, 14.29% (2) of current holders sold a part of the shares held, and 28.57% (4) closed the holdings completely. 3 hedge funds are new holders of ESSA Pharma Inc. stock in Q1 2023, it is 21.43% of total holders.
Hedge funds holding ESSA Pharma (Q2 2018 – Q1 2023)
| Q2 2018 | 8 |
|---|---|
| Q3 2018 | 7 |
| Q4 2018 | 7 |
| Q1 2019 | 7 |
| Q2 2019 | 7 |
| Q3 2019 | 12 |
| Q4 2019 | 17 |
| Q1 2020 | 14 |
| Q2 2020 | 18 |
| Q3 2020 | 32 |
| Q4 2020 | 37 |
| Q1 2021 | 67 |
| Q2 2021 | 77 |
| Q3 2021 | 73 |
| Q4 2021 | 57 |
| Q1 2022 | 66 |
| Q2 2022 | 53 |
| Q3 2022 | 48 |
| Q4 2022 | 40 |
| Q1 2023 | 14 |
Hedge funds changes in ESSA Pharma positions (Q2 2018 – Q1 2023)
| Q2 2018 | 7 | 0 | 1 | 9 | -9 |
|---|---|---|---|---|---|
| Q3 2018 | 1 | 3 | 1 | 2 | 0 |
| Q4 2018 | 2 | 1 | 1 | 1 | 2 |
| Q1 2019 | 0 | 2 | 0 | 0 | 5 |
| Q2 2019 | 0 | 2 | 1 | 0 | 4 |
| Q3 2019 | 5 | 5 | 0 | 0 | 2 |
| Q4 2019 | 6 | 1 | 1 | 1 | 8 |
| Q1 2020 | 2 | 2 | 4 | 4 | 2 |
| Q2 2020 | 5 | 4 | 4 | 1 | 4 |
| Q3 2020 | 14 | 11 | 4 | 0 | 3 |
| Q4 2020 | 7 | 14 | 9 | 2 | 5 |
| Q1 2021 | 36 | 19 | 9 | 6 | -3 |
| Q2 2021 | 18 | 22 | 21 | 8 | 8 |
| Q3 2021 | 19 | 24 | 20 | 21 | -11 |
| Q4 2021 | 5 | 25 | 19 | 22 | -14 |
| Q1 2022 | 19 | 21 | 14 | 10 | 2 |
| Q2 2022 | 6 | 10 | 20 | 19 | -2 |
| Q3 2022 | 9 | 13 | 14 | 14 | -2 |
| Q4 2022 | 10 | 8 | 15 | 18 | -11 |
| Q1 2023 | 3 | 4 | 2 | 4 | 1 |
Hedge funds changes in ESSA Pharma stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 171,000 | 9,000 |
| Q1 2022 | 146,000 | 2,000 |
| Q2 2022 | 56,000 | 0 |
| Q3 2022 | 80,000 | 0 |
| Q4 2022 | 109,320 | 216,216 |
| Q1 2023 | 254,270,000 | 76,000 |